Steward Partners Investment Advisory’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-15
| Closed | -$8 | – | 4190 |
|
|
2024
Q4 | $8 | Hold |
15
| – | – | ﹤0.01% | 3960 |
|
|
2024
Q3 | $20 | Hold |
15
| – | – | ﹤0.01% | 3715 |
|
|
2024
Q2 | $114 | Hold |
15
| – | – | ﹤0.01% | 3552 |
|
|
2024
Q1 | $135 | Hold |
15
| – | – | ﹤0.01% | 3495 |
|
|
2023
Q4 | $161 | Hold |
15
| – | – | ﹤0.01% | 3421 |
|
|
2023
Q3 | $90 | Hold |
15
| – | – | ﹤0.01% | 3320 |
|
|
2023
Q2 | $104 | Hold |
15
| – | – | ﹤0.01% | 3267 |
|
|
2023
Q1 | $236 | Hold |
15
| – | – | ﹤0.01% | 3220 |
|
|
2022
Q4 | $300 | Hold |
15
| – | – | ﹤0.01% | 3230 |
|
|
2022
Q3 | $0 | Hold |
15
| – | – | ﹤0.01% | 3440 |
|
|
2022
Q2 | $0 | Hold |
15
| – | – | ﹤0.01% | 3422 |
|
|
2022
Q1 | $0 | Hold |
15
| – | – | ﹤0.01% | 3414 |
|
|
2021
Q4 | $1K | Hold |
15
| – | – | ﹤0.01% | 3148 |
|
|
2021
Q3 | $1K | Hold |
15
| – | – | ﹤0.01% | 3119 |
|
|
2021
Q2 | $1K | Sell |
15
-350
| -96% | -$23.3K | ﹤0.01% | 7003 |
|
|
2021
Q1 | $60.7K | Buy |
365
+350
| +2,333% | +$58.2K | ﹤0.01% | 1883 |
|
|
2020
Q4 | $1K | Buy |
+15
| New | +$1K | ﹤0.01% | 2836 |
|